• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雪硅钙石纳米纤维的体外羟基磷灰石形成能力及溶解性

In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.

作者信息

Lin Kaili, Chang Jiang, Cheng Rongming

机构信息

Center of Functional Nanomaterials and Devices, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, PR China.

出版信息

Acta Biomater. 2007 Mar;3(2):271-6. doi: 10.1016/j.actbio.2006.11.003. Epub 2007 Jan 17.

DOI:10.1016/j.actbio.2006.11.003
PMID:17234465
Abstract

In this paper, fiber-like and dispersible tobermorite (Ca(5)(Si(6)O(16))(OH)(2).4H(2)O), 80-120 nm in diameter and up to tens of micrometers in length was prepared by a hydrothermal microemulsion method. In vitro bioactivity of the nanofibers were evaluated by examing the hydroxyapatite (HAp) forming ability on the surface after soaking in simulated body fluid (SBF) for various periods. After soaking in SBF, the nanofibers were completely covered by bonelike hydroxycarbonate apatite (HCA) layers, and the nanofibers after soaking still kept stability in fibrous morphology. The dissolution of the nanofibers reached about 24.5% after soaking in SBF for 14 days. The results suggested that the tobermorite nanofibers exhibited certain desirable characteristics, including bioactivity, degradability and stability in morphology, and are a potential candidate for a reinforcement material in the development of novel bioactive and degradable composites for biomedical applications.

摘要

本文采用水热微乳液法制备了直径为80 - 120 nm、长度达数十微米的纤维状且可分散的雪硅钙石(Ca(5)(Si(6)O(16))(OH)(2).4H(2)O)。通过检测纳米纤维在模拟体液(SBF)中浸泡不同时间后表面形成羟基磷灰石(HAp)的能力,对其体外生物活性进行了评估。浸泡在SBF中后,纳米纤维完全被类骨羟基碳酸磷灰石(HCA)层覆盖,浸泡后的纳米纤维在纤维形态上仍保持稳定。在SBF中浸泡14天后,纳米纤维的溶解率达到约24.5%。结果表明,雪硅钙石纳米纤维具有某些理想的特性,包括生物活性、可降解性和形态稳定性,是开发用于生物医学应用的新型生物活性和可降解复合材料的增强材料的潜在候选者。

相似文献

1
In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.雪硅钙石纳米纤维的体外羟基磷灰石形成能力及溶解性
Acta Biomater. 2007 Mar;3(2):271-6. doi: 10.1016/j.actbio.2006.11.003. Epub 2007 Jan 17.
2
Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds.生物活性硅灰石/聚(3-羟基丁酸酯-co-3-羟基戊酸酯)复合支架的制备与表征
Biomaterials. 2004 Nov;25(24):5473-80. doi: 10.1016/j.biomaterials.2003.12.052.
3
Synthesis and in vitro bioactivity of bredigite powders.钙黄长石粉末的合成及其体外生物活性
J Biomater Appl. 2007 Jan;21(3):251-63. doi: 10.1177/0885328206062360. Epub 2006 Mar 16.
4
In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.硅酸钙、硅酸二镁和磷酸三钙生物陶瓷的体外降解、生物活性及细胞相容性
J Biomater Appl. 2009 Aug;24(2):139-58. doi: 10.1177/0885328208094745. Epub 2008 Sep 18.
5
In situ hydroxyapatite nanofiber growth on calcium borate silicate ceramics in SBF and its structural characteristics.在模拟体液中硼硅酸钙陶瓷上原位生长羟基磷灰石纳米纤维及其结构特征。
Mater Sci Eng C Mater Biol Appl. 2015 Oct;55:126-30. doi: 10.1016/j.msec.2015.05.053. Epub 2015 May 21.
6
Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.用于硬组织修复的β-硅酸钙/β-磷酸钙复合材料:体外研究
J Biomed Mater Res A. 2008 Apr;85(1):72-82. doi: 10.1002/jbm.a.31390.
7
Effects of lithium fluoride and maleic acid on the bioactivity of calcium aluminate cement: Formation of hydroxyapatite in simulated body fluid.氟化锂和马来酸对铝酸钙水泥生物活性的影响:在模拟体液中羟基磷灰石的形成。
J Biomed Mater Res A. 2003 Oct 1;67(1):104-11. doi: 10.1002/jbm.a.10036.
8
Effect of Mn-Zn ferrite on apatite-wollastonite glass-ceramic (A-W GC).锰锌铁氧体对磷灰石-硅灰石微晶玻璃(A-W GC)的影响。
Biomed Mater. 2009 Aug;4(4):045001. doi: 10.1088/1748-6041/4/4/045001. Epub 2009 Jun 15.
9
Bioactivity and biocompatibility of a chitosan-tobermorite composite membrane for guided tissue regeneration.壳聚糖托贝莫来石复合膜的引导组织再生的生物活性和生物相容性。
Int J Biol Macromol. 2014 Mar;64:11-6. doi: 10.1016/j.ijbiomac.2013.11.020. Epub 2013 Dec 1.
10
Bioactivity in in situ hydroxyapatite-polycaprolactone composites.原位羟基磷灰石-聚己内酯复合材料的生物活性
J Biomed Mater Res A. 2006 Sep 15;78(4):772-80. doi: 10.1002/jbm.a.30774.

引用本文的文献

1
Synthesis and investigation on microstructural, mechanical features of mesoporous hardystonite/reduced graphene oxide nanocomposite for medical applications.用于医学应用的介孔钙黄长石/还原氧化石墨烯纳米复合材料的合成及其微观结构和力学性能研究
Front Bioeng Biotechnol. 2023 Mar 13;11:1073435. doi: 10.3389/fbioe.2023.1073435. eCollection 2023.
2
The development of collagen based composite scaffolds for bone regeneration.用于骨再生的基于胶原蛋白的复合支架的研发。
Bioact Mater. 2017 Sep 18;3(1):129-138. doi: 10.1016/j.bioactmat.2017.08.004. eCollection 2018 Mar.
3
A simple approach for synthesis, characterization and bioactivity of bovine bones to fabricate the polyurethane nanofiber containing hydroxyapatite nanoparticles.
一种用于牛骨合成、表征及生物活性的简单方法,以制备含羟基磷灰石纳米颗粒的聚氨酯纳米纤维。
Express Polym Lett. 2012;6(1). doi: 10.3144/expresspolymlett.2012.5.
4
Microstructure and chemistry affects apatite nucleation on calcium phosphate bone graft substitutes.微观结构和化学成分会影响磷酸钙骨移植替代物上磷灰石的成核。
J Mater Sci Mater Med. 2013 Mar;24(3):597-610. doi: 10.1007/s10856-012-4833-x. Epub 2012 Dec 16.
5
Aspects of the in vitro bioactivity and antimicrobial properties of Ag(+)- and Zn (2+)-exchanged 11 A tobermorites.Ag(+)和Zn(2+)交换的11Å雪硅钙石的体外生物活性和抗菌性能方面
J Mater Sci Mater Med. 2009 Jun;20(6):1347-55. doi: 10.1007/s10856-009-3698-0. Epub 2009 Feb 13.